The size of the Sleep Apnea Devices market in Middle East Africa is predicted to value USD 0.27 billion in 2023 and USD 0.30 billion by 2028, growing at a CAGR of 1.8% from 2023 to 2028.
The rise in the number of people suffering from sleeping disorders is straight accelerating the demand; especially, the problem is widespread in urban populations and metropolitan cities, leading to the constant rise in demand for sleep apnea devices. In the Middle East and Africa, government authorities are taking initial steps to enhance healthcare services and with advanced sleep labs and sleep tests and therapies such as Hyoglossus Nerve Stimulation and expiratory positive air pressure, contributing to the growth of this market. The advanced devices are constantly emerging into the market owing to intensive research and technological developments, which are highly convenient for diagnosis and therapies, propelling the growth of the sleep apnea devices market in the Middle East and Africa. In addition, the increasing expenditure of hospitals and diagnostics centers in the Middle East and Africa is also boosting the growth rate of the MEA sleep apnea devices market.
The masks used for therapies are causing claustrophobia or discomfort to patients and is limiting the growth rate of sleep apnea devices in the Middle East and Africa. In addition, high costs associated with sleep apnea devices like CPAP and lack of proper reimbursement policies, and difficulties of insurance accessibility are likely to restrain the growth of the sleep apnea devices market during the forecast period.
Growing incidences of unhealthy sleeping habits among many individuals and their prevalence for effective treatment procedures are anticipated to boost the market's demand and increase growth opportunities for the key players in the market. Increasing focus on initiatives from the private and public organizations for developing innovative sleep apnea therapies and devices is expected to be creating growth opportunities for the market. The increasing prevalence of obesity due to unhealthy eating habits is expected to be fuelling the growth rate of the sleep apnea devices market in the Middle East and Africa. R & D organizations and academic institutions are focusing on developing innovative products with advanced technology to enhance the efficiency of diagnosis, therapies, and devices, which are expected to boost the demand of the market in the Middle East and Africa. In addition, rapid developments of smartphones integrated with sensors are expected to provide lucrative growth opportunities for the MEA sleep apnea devices market.
This research report on the MEA sleep apnea devices market has been segmented and sub-segmented into the following categories:
By Diagnostic Devices:
By Therapeutic Devices:
Regionally, the Saudi Arabian sleep apnea devices market is estimated to lead the MEA regional market during the forecast period. The factors contributing to the growth are the increasing incidence of obesity, leading to a rise in demand for sleep apnea devices, and technological advancements. On the other hand, the UAE sleep apnea devices market has contributed a significant share of revenues to the MEA market. It is likely to maintain the trend owing to the factors such as the emergence of innovative therapeutic diagnoses and devices for sleep apnea in the market, inappropriate sleeping habits, and increasing focus of key market players in R & D activities in this region.
KEY MARKET PLAYERS:
A few of the promising companies operating in the MEA Sleep Apnea Devices Market profiled in this report are ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other players in the market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), and Whole You, Inc. (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org